Hims & Hers Health, Inc. (HIMS): Price and Financial Metrics

Hims & Hers Health, Inc. (HIMS): $6.29

0.07 (-1.10%)

POWR Rating

Component Grades








Add HIMS to Watchlist
Sign Up

Industry: Medical - Services




#39 of 69

in industry

HIMS Price/Volume Stats

Current price $6.29 52-week high $12.34
Prev. close $6.36 52-week low $4.01
Day low $6.24 Volume 2,028,100
Day high $6.54 Avg. volume 3,034,674
50-day MA $7.09 Dividend yield N/A
200-day MA $8.56 Market Cap 1.33B

HIMS Stock Price Chart Interactive Chart >


  • HIMS scores best on the Growth dimension, with a Growth rank ahead of 93.43% of US stocks.
  • HIMS's strongest trending metric is Quality; it's been moving up over the last 177 days.
  • HIMS's current lowest rank is in the Stability metric (where it is better than 6.99% of US stocks).

HIMS Stock Summary

  • Price to trailing twelve month operating cash flow for HIMS is currently 49.59, higher than 92.98% of US stocks with positive operating cash flow.
  • The ratio of debt to operating expenses for HIMS & HERS HEALTH INC is higher than it is for about just 4.86% of US stocks.
  • As for revenue growth, note that HIMS's revenue has grown 90.16% over the past 12 months; that beats the revenue growth of 94.07% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to HIMS & HERS HEALTH INC, a group of peers worth examining would be VEEE, CREX, AYTU, TOMZ, and ASUR.
  • HIMS's SEC filings can be seen here. And to visit HIMS & HERS HEALTH INC's official web site, go to www.forhims.com.

HIMS Valuation Summary

  • In comparison to the median Consumer Defensive stock, HIMS's price/sales ratio is 0% higher, now standing at 1.8.
  • HIMS's price/sales ratio has moved NA NA over the prior 51 months.

Below are key valuation metrics over time for HIMS.

Stock Date P/S P/B P/E EV/EBIT
HIMS 2023-09-22 1.8 4.0 -27.0 -25.8
HIMS 2023-09-21 1.8 4.0 -27.4 -26.3
HIMS 2023-09-20 1.8 4.1 -27.8 -26.6
HIMS 2023-09-19 1.9 4.1 -28.0 -26.9
HIMS 2023-09-18 1.9 4.2 -28.5 -27.3
HIMS 2023-09-15 1.9 4.2 -28.3 -27.2

HIMS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • HIMS has a Quality Grade of C, ranking ahead of 40.35% of graded US stocks.
  • HIMS's asset turnover comes in at 1.028 -- ranking 21st of 81 Healthcare stocks.
  • 500 - Internal server error

The table below shows HIMS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.028 0.752 -0.439
2021-03-31 0.917 0.744 -0.393
2020-12-31 0.807 0.736 -0.105
2020-09-30 0.521 0.723 -0.059
2020-09-30 0.521 0.723 -0.059
2020-09-30 0.521 0.723 -0.059

Hims & Hers Health, Inc. (HIMS) Company Bio

Hims & Hers Health, Inc. provides health care software solutions. The Company offers multi-specialty telehealth platform that connects consumers to licensed healthcare providers, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, and primary care. Hims & Hers Health serves customers in the United States.

HIMS Latest News Stream

Event/Time News Detail
Loading, please wait...

HIMS Latest Social Stream

Loading social stream, please wait...

View Full HIMS Social Stream

Latest HIMS News From Around the Web

Below are the latest news stories about HIMS & HERS HEALTH INC that investors may wish to consider to help them evaluate HIMS as an investment opportunity.

Rocket Stocks: 3 Investments Primed to Skyrocket by Year’s End

Three companies have thrived thanks to their innovative strategies and adaptability in the face of change.

Yiannis Zourmpanos on InvestorPlace | September 27, 2023

Hims & Hers Named on Fortune Media and Great Place to Work’s 2023 Best Workplaces in Health Care List

SAN FRANCISCO, September 06, 2023--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced Great Place To Work® and Fortune magazine named the company on the 2023 Fortune Best Workplaces in Health Care™ List.

Yahoo | September 6, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're starting off the day with a look at all of the biggest pre-market stock movers worth keeping an eye on for Tuesday!

William White on InvestorPlace | August 8, 2023

Moody's bank downgrades, Novavax, Hims & Hers, Olaplex: Trending stocks

Moody's analysts have downgraded several small and mid-sized banks, while other banks remain on a downgrade watch over financial conditions. Novavax (NVAX) reports a surprise second-quarter profit tied to its COVID-19 vaccine. Health and wellness company Hims & Hers (HIMS) sees shares rise on a revenue beat and raising full-year guidance. Olaplex (OLPX) stock dips as retail sales plunge amid a demand slump. Yahoo Finance Live anchor Julie Hyman takes a look at several trending stocks in the morning trading session.

Yahoo | August 8, 2023

Hims & Hers weight loss business to launch by end of 2023

Hims & Hers to enter into lucrative weight loss market.

Yahoo | August 7, 2023

Read More 'HIMS' Stories Here

HIMS Price Returns

1-mo -6.26%
3-mo -33.09%
6-mo -38.99%
1-year 12.72%
3-year -46.47%
5-year N/A
YTD -1.87%
2022 -2.14%
2021 -55.14%
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!